InformasjonSjøgrens syndrom rammer i 90 prosent av tilfellene kvinner.
Sjøgrens syndrom
Sjøgrens syndrom er en betennelse som rammer kroppens kjertler og gir symptomer som tørr munn og tørre øyne. Mange pasienter har i tillegg uklare plager som leddsmerter, muskelsmerter og tretthet.
Sist oppdatert:
15. sep. 2020
Dette dokumentet er basert på det profesjonelle dokumentet Sjøgrens syndrom . Referanselisten for dette dokumentet vises nedenfor
Referanser
- Fox RI. Sjögren's syndrome. Lancet 2005; 366: 321-31. PubMed
- Kruszka P, O'Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician 2009; 79: 465-70. American Family Physician
- Kurien BT, Scofield RH. Sjogren's syndrome. BMJ Best Practice, last updated May 23, 2016. bestpractice.bmj.com
- Bowman SJ, Ibrahim GH, Holmes G, Hamburger J and Ainsworth JR. Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK. Scand J Rheumatol 2004; 33: 39-43. PubMed
- Kabasakal Y, Kitapciglu G, Turk T, et al. The prevalence of Sjogren's syndrome in adult women. Scand J Rheumatol. 2006;35:379-383. PubMed
- Pillemer SR, Matteson EL, Jacobsson LT et al. Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County. Minnesota, Mayo Clin Proc 2001; 76: 593-9.
- Cimaz R, Casadei A, Rose C et al. Primary Sjögren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr 2003; 162: 661-5. PubMed
- García-Carrasco M, Ramos-Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002; 81: 270-80. PubMed
- Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013;9:544-556. PubMed
- Cummins MJ, Papas A, Kammer GM, Fox PC. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum 2003; 49: 585-93. PubMed
- Mariette X, Ravaud P, Steinfeld S, et al. Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum 2004; 50: 1270-6. PubMed
- Manoussakis MN, Georgopoulou C, Zintzaras E et al. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum 2004; 50: 882-91. PubMed
- Baer AN. Diagnosis and classification of Sjögren's syndrome. UpToDate, last updated Sep 11, 2018. www.uptodate.com
- Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 2017; 69:35. PubMed
- Mariette X, Criswell LA. Primary Sjögren’s Syndrome. N Engl J Med 2018; 378: 931-39. pmid:29514034 PubMed
- Lwin CT, Bishay M, Platts RG, Booth DA and Bowman SJ. The assessment of fatigue in primary Sjögren's syndrome. Scand J Rheumatol 2003; 32: 33-7. PubMed
- Lindvall B, Bengtsson A, Ernerudh J and Eriksson P. Subclinical myositis is common in primary Sjögren's syndrome and is not related to muscle pain. J Rheumatol 2002; 29: 717-25. PubMed
- Nocturne G, Mariette X. Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol 2015; 168:317. PubMed
- Ramos-Casals M, Anaya JM, Garcia-Carrasco M et al. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004; 83: 96-106. PubMed
- Roguedas AM, Misery L, Sassolas B, Le Masson G, Pennec YL and Youinou P. Cutaneous manifestations of primary Sjögren's syndrome are underestimated. Clin Exp Rheumatol 2004; 22: 632-6. PubMed
- Chung WS, Lin CL, Sung FC, et al. Increased risks of deep vein thrombosis and pulmonary embolism in Sjogren syndrome: a nationwide cohort study. J Rheumatol. 2014;41:909-915. PubMed
- Gamron S, Barberis G, Onetti CM et al. Mesangial nephropathy in Sjögren's syndrome. Scand J Rheumatol 2000; 29; 65-7.
- Leppilahti M, Tammela TL, Huhtala H, Kiilholma P, Leppilahti K and Auvinen A. Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: a population-based study in Finland. Am J Med 2003; 115: 62-5. PubMed
- D'Arbonneau F, Ansart S, Le Berre R, Dueymes M, Youinou P and Pennec YL. Thyroid dysfunction in primary Sjögren's syndrome: a long-term followup study. Arthritis Rheum 2003; 49: 804-9. PubMed
- Delalande S, de Seze J, Fauchais AL et al. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore) 2004; 83: 280-91. PubMed
- Scofield AK, Radfar L, Ice JA, et al. Relation of sensory peripheral neuropathy in Sjogren syndrome to anti-Ro/SSA. J Clin Rheumatol. 2012;18:290-293. PubMed
- Scheinfeld N. Sjogren syndrome and systemic lupus erythematosus are distinct conditions. Dermatol Online J. 2006;12:4. PubMed
- Gran JT, Myklebust G. Diagnostikk av primært Sjögrens syndrom. Tidsskr Nor Lægeforen 2001; 121: 563-6. Tidsskrift for Den norske legeforening
- Jonsson MV, Baldini C. Major salivary gland ultrasonography in the diagnosis of Sjogren’s syndrome - a place in the diagnostic criteria? Rheum Dis Clin North Am. 2016 Aug;42(3):501-17. PMID: 27431351. PubMed
- Vivino FB, Gala I and Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol 2002; 29: 938-44. PubMed
- Baer AN, Vivino FB. Treatment of Sjögren's syndrome: Constitutional and non-sicca organ-based manifestations. UpToDate, last updated Apr 06, 2020. UpToDate
- Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch Intern Med 2004; 164: 1275-84. PubMed
- Baer AN, Sankar V. Treatment of dry mouth and other non-ocular sicca symptoms in Sjögren's syndrome. UpToDate, last updated Jul 11, 2020. UpToDate
- Belafsky PC and Postma GN. The laryngeal and esophageal manifestations of Sjögren's syndrome. Curr Rheumatol Rep 2003; 5: 297-303. PubMed
- Wang SQ, Zhang LW, Wei P, Hua H. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis. BMC Musculoskelet Disord 2017; 18: 186. pmid:28499370 PubMed
- Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sjogren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014; 160: 233-42. PMID: 24727841 PubMed
- Bowman SJ, Everett CC, O`Dwyer JL, et al. Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjogren`s Syndrome. Arthritis Rheumatol. 2017; 69: 1440-50. PMID: 28296257 PubMed
- He J, Chen J, Miao M, et al. Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome A Randomized Clinical Trial. JAMA Netw Open 2022; 5: e2241451. doi:10.1001/jamanetworkopen.2022.41451 DOI
- Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 2337-44. PubMed
- Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002; 46: 741-7. PubMed